APO Research

APO RESEARCH · REPORT

Image-based FFR Diagnosis

Selected research

Market Outlook & Growth Opportunities

Global Image-based FFR Diagnosis Market Outlook and Growth Opportunities 2026

Market perspective

The global Image-based FFR Diagnosis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Image-based FFR Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Image-based FFR Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Image-based FFR Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Image-based FFR Diagnosis market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Image-based FFR Diagnosis market include HeartFlow, Medis QFR, Beijing Heart Century, Raysight, Keya Medical, ArteryFlow Technology, Pulse Medical Imaging, Fosun Aitrox and Beijing GuanShengYun, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Image-based FFR Diagnosis market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Image-based FFR Diagnosis and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Image-based FFR Diagnosis revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Image-based FFR Diagnosis market.

Image-based FFR Diagnosis Segment by Company

HeartFlow

Medis QFR

Beijing Heart Century

Raysight

Keya Medical

ArteryFlow Technology

Pulse Medical Imaging

Fosun Aitrox

Beijing GuanShengYun

Shukun

ShengShi

Image-based FFR Diagnosis Segment by Type

CT-FFR

QFR

Others

Image-based FFR Diagnosis Segment by Application

Hospital

Imaging Center

Image-based FFR Diagnosis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Image-based FFR Diagnosis status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Image-based FFR Diagnosis key companies, revenue, market share, and recent developments.

3. To split the Image-based FFR Diagnosis breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Image-based FFR Diagnosis market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Image-based FFR Diagnosis significant trends, drivers, influence factors in global and regions.

6. To analyze Image-based FFR Diagnosis competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Image-based FFR Diagnosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Image-based FFR Diagnosis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Image-based FFR Diagnosis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Image-based FFR Diagnosis industry.

Chapter 3: Detailed analysis of Image-based FFR Diagnosis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Image-based FFR Diagnosis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Image-based FFR Diagnosis in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Image-based FFR Diagnosis Industry Trends Table 2. Image-based FFR Diagnosis Industry Drivers Table 3. Image-based FFR Diagnosis Industry Opportunities and Challenges Table 4. Image-based FFR Diagnosis Industry Restraints Table 5. Global Image-based FFR Diagnosis Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Image-based FFR Diagnosis Revenue Share by Company (2021-2026) Table 7. Global Image-based FFR Diagnosis Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Image-based FFR Diagnosis Key Company Manufacturing Base & Headquarters Table 9. Global Image-based FFR Diagnosis Company, Product Type & Application Table 10. Global Image-based FFR Diagnosis Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Image-based FFR Diagnosis by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of CT-FFR Table 15. Significant Companies of QFR Table 16. Significant Companies of Others Table 17. Global Image-based FFR Diagnosis Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Image-based FFR Diagnosis Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Image-based FFR Diagnosis Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Image-based FFR Diagnosis Sales Value Share by Type (2021-2026) Table 21. Global Image-based FFR Diagnosis Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Hospital Table 23. Significant Companies of Imaging Center Table 24. Global Image-based FFR Diagnosis Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Image-based FFR Diagnosis Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Image-based FFR Diagnosis Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Image-based FFR Diagnosis Sales Value Share by Application (2021-2026) Table 28. Global Image-based FFR Diagnosis Sales Value Share by Application (2027-2032) Table 29. Global Image-based FFR Diagnosis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Image-based FFR Diagnosis Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Image-based FFR Diagnosis Sales Value Share by Region (2021-2026) Table 32. Global Image-based FFR Diagnosis Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Image-based FFR Diagnosis Sales Value Share by Region (2027-2032) Table 34. Global Image-based FFR Diagnosis Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Image-based FFR Diagnosis Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Image-based FFR Diagnosis Sales Value Market Share by Country (2021-2026) Table 37. Global Image-based FFR Diagnosis Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Image-based FFR Diagnosis Sales Value Market Share by Country (2027-2032) Table 39. HeartFlow Company Information Table 40. HeartFlow Business Overview Table 41. HeartFlow Image-based FFR Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. HeartFlow Image-based FFR Diagnosis Product Portfolio Table 43. HeartFlow Recent Development Table 44. Medis QFR Company Information Table 45. Medis QFR Business Overview Table 46. Medis QFR Image-based FFR Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Medis QFR Image-based FFR Diagnosis Product Portfolio Table 48. Medis QFR Recent Development Table 49. Beijing Heart Century Company Information Table 50. Beijing Heart Century Business Overview Table 51. Beijing Heart Century Image-based FFR Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Beijing Heart Century Image-based FFR Diagnosis Product Portfolio Table 53. Beijing Heart Century Recent Development Table 54. Raysight Company Information Table 55. Raysight Business Overview Table 56. Raysight Image-based FFR Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Raysight Image-based FFR Diagnosis Product Portfolio Table 58. Raysight Recent Development Table 59. Keya Medical Company Information Table 60. Keya Medical Business Overview Table 61. Keya Medical Image-based FFR Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Keya Medical Image-based FFR Diagnosis Product Portfolio Table 63. Keya Medical Recent Development Table 64. ArteryFlow Technology Company Information Table 65. ArteryFlow Technology Business Overview Table 66. ArteryFlow Technology Image-based FFR Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. ArteryFlow Technology Image-based FFR Diagnosis Product Portfolio Table 68. ArteryFlow Technology Recent Development Table 69. Pulse Medical Imaging Company Information Table 70. Pulse Medical Imaging Business Overview Table 71. Pulse Medical Imaging Image-based FFR Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Pulse Medical Imaging Image-based FFR Diagnosis Product Portfolio Table 73. Pulse Medical Imaging Recent Development Table 74. Fosun Aitrox Company Information Table 75. Fosun Aitrox Business Overview Table 76. Fosun Aitrox Image-based FFR Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Fosun Aitrox Image-based FFR Diagnosis Product Portfolio Table 78. Fosun Aitrox Recent Development Table 79. Beijing GuanShengYun Company Information Table 80. Beijing GuanShengYun Business Overview Table 81. Beijing GuanShengYun Image-based FFR Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Beijing GuanShengYun Image-based FFR Diagnosis Product Portfolio Table 83. Beijing GuanShengYun Recent Development Table 84. Shukun Company Information Table 85. Shukun Business Overview Table 86. Shukun Image-based FFR Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Shukun Image-based FFR Diagnosis Product Portfolio Table 88. Shukun Recent Development Table 89. ShengShi Company Information Table 90. ShengShi Business Overview Table 91. ShengShi Image-based FFR Diagnosis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. ShengShi Image-based FFR Diagnosis Product Portfolio Table 93. ShengShi Recent Development Table 94. Research Programs/Design for This Report Table 95. Authors List of This Report Table 96. Secondary Sources Table 97. Primary Sources List of Figures Figure 1. Image-based FFR Diagnosis Product Image Figure 2. Global Image-based FFR Diagnosis Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Image-based FFR Diagnosis Market Size (2021-2032) & (US$ Million) Figure 4. Global Image-based FFR Diagnosis Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. CT-FFR Image Figure 8. QFR Image Figure 9. Others Image Figure 10. Global Image-based FFR Diagnosis Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Image-based FFR Diagnosis Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Image-based FFR Diagnosis Sales Value Share by Type (2021-2032) Figure 13. Hospital Image Figure 14. Imaging Center Image Figure 15. Global Image-based FFR Diagnosis Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Image-based FFR Diagnosis Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Image-based FFR Diagnosis Sales Value Share by Application (2021-2032) Figure 18. Global Image-based FFR Diagnosis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Image-based FFR Diagnosis Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Image-based FFR Diagnosis Sales Value (2021-2032) & (US$ Million) Figure 21. North America Image-based FFR Diagnosis Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Image-based FFR Diagnosis Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Image-based FFR Diagnosis Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Image-based FFR Diagnosis Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Image-based FFR Diagnosis Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Image-based FFR Diagnosis Sales Value (2021-2032) & (US$ Million) Figure 27. South America Image-based FFR Diagnosis Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Image-based FFR Diagnosis Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Image-based FFR Diagnosis Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • CT-FFR
  • QFR
  • Others
Applications
  • Hospital
  • Imaging Center
Companies covered
  • HeartFlow
  • Medis QFR
  • Beijing Heart Century
  • Raysight
  • Keya Medical
  • ArteryFlow Technology
  • Pulse Medical Imaging
  • Fosun Aitrox
  • Beijing GuanShengYun
  • Shukun
  • ShengShi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Image-based FFR Diagnosis Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Image-based FFR Diagnosis Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Image-based FFR Diagnosis Market Dynamics
  1. 2.1 Image-based FFR Diagnosis Industry Trends
  2. 2.2 Image-based FFR Diagnosis Industry Drivers
  3. 2.3 Image-based FFR Diagnosis Industry Opportunities and Challenges
  4. 2.4 Image-based FFR Diagnosis Industry Restraints
3 Image-based FFR Diagnosis Market by Company
  1. 3.1 Global Image-based FFR Diagnosis Company Revenue Ranking in 2025
  2. 3.2 Global Image-based FFR Diagnosis Revenue by Company (2021-2026)
  3. 3.3 Global Image-based FFR Diagnosis Company Ranking (2024-2026)
  4. 3.4 Global Image-based FFR Diagnosis Company Manufacturing Base and Headquarters
  5. 3.5 Global Image-based FFR Diagnosis Company Product Type and Application
  6. 3.6 Global Image-based FFR Diagnosis Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Image-based FFR Diagnosis Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Image-based FFR Diagnosis Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Image-based FFR Diagnosis Market by Type
  1. 4.1 Image-based FFR Diagnosis Type Introduction
  2. 4.1.1 CT-FFR
  3. 4.1.2 QFR
  4. 4.1.3 Others
  5. 4.2 Global Image-based FFR Diagnosis Sales Value by Type
  6. 4.2.1 Global Image-based FFR Diagnosis Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Image-based FFR Diagnosis Sales Value by Type (2021-2032)
  8. 4.2.3 Global Image-based FFR Diagnosis Sales Value Share by Type (2021-2032)
5 Image-based FFR Diagnosis Market by Application
  1. 5.1 Image-based FFR Diagnosis Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Imaging Center
  4. 5.2 Global Image-based FFR Diagnosis Sales Value by Application
  5. 5.2.1 Global Image-based FFR Diagnosis Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Image-based FFR Diagnosis Sales Value by Application (2021-2032)
  7. 5.2.3 Global Image-based FFR Diagnosis Sales Value Share by Application (2021-2032)
6 Image-based FFR Diagnosis Regional Value Analysis
  1. 6.1 Global Image-based FFR Diagnosis Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Image-based FFR Diagnosis Sales Value by Region (2021-2032)
  3. 6.2.1 Global Image-based FFR Diagnosis Sales Value by Region: 2021-2026
  4. 6.2.2 Global Image-based FFR Diagnosis Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Image-based FFR Diagnosis Sales Value (2021-2032)
  7. 6.3.2 North America Image-based FFR Diagnosis Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Image-based FFR Diagnosis Sales Value (2021-2032)
  10. 6.4.2 Europe Image-based FFR Diagnosis Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Image-based FFR Diagnosis Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Image-based FFR Diagnosis Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Image-based FFR Diagnosis Sales Value (2021-2032)
  16. 6.6.2 South America Image-based FFR Diagnosis Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Image-based FFR Diagnosis Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Image-based FFR Diagnosis Sales Value Share by Country, 2025 VS 2032
7 Image-based FFR Diagnosis Country-level Value Analysis
  1. 7.1 Global Image-based FFR Diagnosis Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Image-based FFR Diagnosis Sales Value by Country (2021-2032)
  3. 7.2.1 Global Image-based FFR Diagnosis Sales Value by Country (2021-2026)
  4. 7.2.2 Global Image-based FFR Diagnosis Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Image-based FFR Diagnosis Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Image-based FFR Diagnosis Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Image-based FFR Diagnosis Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 HeartFlow
  2. 8.1.1 HeartFlow Company Information
  3. 8.1.2 HeartFlow Business Overview
  4. 8.1.3 HeartFlow Image-based FFR Diagnosis Revenue and Gross Margin (2021-2026)
  5. 8.1.4 HeartFlow Image-based FFR Diagnosis Product Portfolio
  6. 8.1.5 HeartFlow Recent Developments
  7. 8.2 Medis QFR
  8. 8.2.1 Medis QFR Company Information
  9. 8.2.2 Medis QFR Business Overview
  10. 8.2.3 Medis QFR Image-based FFR Diagnosis Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Medis QFR Image-based FFR Diagnosis Product Portfolio
  12. 8.2.5 Medis QFR Recent Developments
  13. 8.3 Beijing Heart Century
  14. 8.3.1 Beijing Heart Century Company Information
  15. 8.3.2 Beijing Heart Century Business Overview
  16. 8.3.3 Beijing Heart Century Image-based FFR Diagnosis Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Beijing Heart Century Image-based FFR Diagnosis Product Portfolio
  18. 8.3.5 Beijing Heart Century Recent Developments
  19. 8.4 Raysight
  20. 8.4.1 Raysight Company Information
  21. 8.4.2 Raysight Business Overview
  22. 8.4.3 Raysight Image-based FFR Diagnosis Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Raysight Image-based FFR Diagnosis Product Portfolio
  24. 8.4.5 Raysight Recent Developments
  25. 8.5 Keya Medical
  26. 8.5.1 Keya Medical Company Information
  27. 8.5.2 Keya Medical Business Overview
  28. 8.5.3 Keya Medical Image-based FFR Diagnosis Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Keya Medical Image-based FFR Diagnosis Product Portfolio
  30. 8.5.5 Keya Medical Recent Developments
  31. 8.6 ArteryFlow Technology
  32. 8.6.1 ArteryFlow Technology Company Information
  33. 8.6.2 ArteryFlow Technology Business Overview
  34. 8.6.3 ArteryFlow Technology Image-based FFR Diagnosis Revenue and Gross Margin (2021-2026)
  35. 8.6.4 ArteryFlow Technology Image-based FFR Diagnosis Product Portfolio
  36. 8.6.5 ArteryFlow Technology Recent Developments
  37. 8.7 Pulse Medical Imaging
  38. 8.7.1 Pulse Medical Imaging Company Information
  39. 8.7.2 Pulse Medical Imaging Business Overview
  40. 8.7.3 Pulse Medical Imaging Image-based FFR Diagnosis Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pulse Medical Imaging Image-based FFR Diagnosis Product Portfolio
  42. 8.7.5 Pulse Medical Imaging Recent Developments
  43. 8.8 Fosun Aitrox
  44. 8.8.1 Fosun Aitrox Company Information
  45. 8.8.2 Fosun Aitrox Business Overview
  46. 8.8.3 Fosun Aitrox Image-based FFR Diagnosis Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Fosun Aitrox Image-based FFR Diagnosis Product Portfolio
  48. 8.8.5 Fosun Aitrox Recent Developments
  49. 8.9 Beijing GuanShengYun
  50. 8.9.1 Beijing GuanShengYun Company Information
  51. 8.9.2 Beijing GuanShengYun Business Overview
  52. 8.9.3 Beijing GuanShengYun Image-based FFR Diagnosis Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Beijing GuanShengYun Image-based FFR Diagnosis Product Portfolio
  54. 8.9.5 Beijing GuanShengYun Recent Developments
  55. 8.10 Shukun
  56. 8.10.1 Shukun Company Information
  57. 8.10.2 Shukun Business Overview
  58. 8.10.3 Shukun Image-based FFR Diagnosis Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Shukun Image-based FFR Diagnosis Product Portfolio
  60. 8.10.5 Shukun Recent Developments
  61. 8.11 ShengShi
  62. 8.11.1 ShengShi Company Information
  63. 8.11.2 ShengShi Business Overview
  64. 8.11.3 ShengShi Image-based FFR Diagnosis Revenue and Gross Margin (2021-2026)
  65. 8.11.4 ShengShi Image-based FFR Diagnosis Product Portfolio
  66. 8.11.5 ShengShi Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research